GT
VKTX icon

Glenmede Trust’s Viking Therapeutics VKTX Stock Holding History

Glenmede Trust’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-4,028
Closed -$214K – 1431
2024
Q2 		$214K Sell
4,028
-3,021
-43% -$198K ﹤0.01% 1175
2024
Q1 		$578K Buy
+7,049
New +$314K ﹤0.01% 879
2023
Q3 		– Sell
-25,033
Closed -$417K – 1367
2023
Q2 		$417K Hold
25,033
– – ﹤0.01% 882
2023
Q1 		$417K Sell
25,033
-256
-1% -$2.64K ﹤0.01% 887
2022
Q4 		$238K Buy
+25,289
New +$113K ﹤0.01% 1047

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return